Exercise chemosensitivity in heart failure: Ventilatory, chronotropic and neurohormonal responses;Quimiosensibilidad durante ejercicio en la insuficiencia cardíaca: Respuestas ventilatorias, cronotrópicas y neurohormonales

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 3, 2010, Pages 381-391

  Moura, Lídia Zytynski ^a   Guimarães, Guilherme Veiga ^a   Pires, Philippe Vieira ^a   Cruz, Fátima ^a   Stopa, Gabriela ^a   Bocchi, Edimar Alcides ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiomyopathies; Exercise; Heart failure; Nitric oxide; Norepinephrine

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; INTERLEUKIN 6; NEUROHORMONE; NITRIC OXIDE;

ADULT; ALDOSTERONE BLOOD LEVEL; AMBIENT AIR; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CATECHOLAMINE BLOOD LEVEL; CHEMORECEPTOR; CHEMOSENSITIVITY; CHRONOTROPISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART FAILURE; HORMONE RESPONSE; HUMAN; HYPERCAPNIA; HYPOXIA; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIDAL VOLUME; TREADMILL EXERCISE;

EID: 78049332879     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000110     Document Type: Article

References (39)

1. Ciarka A, Cuylits N, Vachiery JL, Lamotte M, Degaute JP, Naeije R, et al. Increased peripheral chemoreceptors sensitivity and exercise ventilation in heart transplant recipients. Circulation. 2006; 113 (2): 252-7. (Pubitemid 43754382)
2. Ainslie PN, Duffin J. - Am J Physiol Regul Integr Comp Physiol. 2009; 296 (5): R1473-95.
3. Somers V, Mark A, Zavala D, Abboud F. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol. 1989; 67 (5): 2095-101.
4. Agostoni P, Apostolo A, Albert RK. Mechanisms of periodic breathing during exercise in patients with chronic heart failure. Chest. 2008; 133 (1): 197-203.
5. Kara T, Narkiewicz K, Somers VK. Chemoreflexes - physiology and clinical implications. Acta Physiol Scand. 2003; 177 (3): 377-84.
6. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, et al. The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure. Am Heart J. 2008; 156 (5): 982-8.
7. Bocchi EA, Guimarães G, Mocelin A, Bacal F, Belotti G, Ramires JF. Sildenafil effects on exercise, neurohormal activation, and erectile dysfunction in congestive heart. Circulation. 2002; 106 (9): 1097-103.
8. Rubim VS, Drumond Neto C, Romeo JL, Montera MW. Prognostic value of the six-minute walk test in heart failure. Arq Bras Cardiol. 2006; 86 (2): 120-5.
9. Guimarães GV, Bellotti G, Bacal F, Michelin A, Bocchi E. Pode o teste ergoespirometrico de caminhada de seis minutos ser representativo das atividades habituais de pacientes com insuficiência cardíaca? Arq Bras Cardiol. 2002; 78 (6): 557-60.
10. Hansson C, Agrup G, Rorsman H, Rosengren AM, Rosengren E, Edholm LE. Analysis of cysteinyldopas, dopa, dopamine, noradrenaline and adrenaline in serum and urine using high-performance liquid chromatography and electrochemical detection. J Chromatogr. 1979; 162 (1): 7-22. (Pubitemid 9065224)
11. Vogeser M, Jacob K. B-type natriuretic peptide (BNP) - validation of an immediate response assay. Clin Lab. 2001; 47 (1-2): 29-33.
12. Walsh PR, Wang MC, Gitterman ML. A simplified radioimmunoassay for plasma aldosterone. Ann Clin Lab Sci. 1981; 11 (2): 138-45.
13. Timmons BW, Hamadeh MJ, Tarnopolsky MA. Two methods for determining plasma IL-6 in humans at rest and following exercise. Eur J Appl Physiol. 2009; 105 (1): 13-8.
14. Easton PA, Slykerman LJ, Anthonisen NR. Ventilatory response to sustained hypoxia in normal adults. J Appl Physiol. 1986; 61: 906-11.
15. Olson LJ, Arruda-Olson AM, Somers VK, Scott CG, Johnson BD. Exercise oscillatory ventilation: instability of breathing control associated with advanced heart failure. Chest. 2008; 133 (2): 474-81.
16. Wensel R, Georgiadou P, Franas DP, Bayne S, Scott AC, Genth-Zotz S, et al. Differential contribution of dead space ventilation and low arterial pCO2 to exercise hyperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2004; 93 (3): 318-23.
17. Bocchi EA, Auler Jr JO, Guimarães GV, Carmona MJ, Wajngarten M, Bellotti G, et al. Nitric oxide inhalation reduces pulmonary tidal volume during exercise in severe chronic heart failure. Am Heart J. 1997; 134 (4): 737-44.
18. Fukuoka Y, Endo M, Oishi Y, Ikegami H. Chemoreflex drive and the dynamics of ventilation and gas exchange during exercise at hypoxia. Am J Respir Crit Care Med. 2003; 168 (9): 1115-22. (Pubitemid 37338942)
19. Peltonen JE, Tikkanen HO, Rusko HK. Cardiorespiratory responses to exercise in acute hypoxia, hyperoxia and normoxia. Eur J Appl Physiol. 2001; 85 (1-2): 82-8.
20. Tanabe Y, Hosaka Y, Ito M, Ito E, Suzuki K. Significance of end-tidal PCO2 response to exercise and its relation to functional capacity inpatients with chronic heart failure. Chest. 2001; 119 (3): 811-7.
21. Hopkins SR, Bogaard HJ, Niizeki K, Yamaya Y, Ziegler MG, Wagner PD. Beta-adrenergic or parasympathetic inhibition, heart rate and cardiac output during normoxic and acute hypoxic exercise in humans. J Physiol. 2003; 550 (Pt 2): 605-16.
22. Van de Borne P, Montano N, Narkiewicz K, Degaute J, Malliani A, Somers V. Importance of ventilation in modulation interaction between sympathetic drive and cardiovascular variability. Am J Physiol Heart Circ Physiol. 2001; 280 (2): H722-729.
23. Duffin J. Measuring the ventilatory response to hypoxia. J Physiol. 2007; 584 (Pt 1): 285-93.
24. Narkiewicz K, Pesek C, Van de Borne P, Kato M, Somers V. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation. 1999; 100 (3): 262-7. (Pubitemid 29340132)
25. Ogoh S, Ainslie PN, Miyamoto T. Onset responses of ventilation and cerebral blood flow to hypercapnia in humans: rest and exercise. J Appl Physiol. 2009; 106 (3): 880-6.
26. Janicki JS, Sheriff DD, Robothan JL, Wise RA. Cardiac output during exercise: contribution of the cardiac, circulatory, and respiratory systems. In: Rowell L, Sheperd JT. (eds). Handbook of physiology. Exercise: regulation and integration of multiple systems. Bethesda: Oxford University Press; 1996.
27. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D, et al. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol. 2006; 575 (Pt 1): 229-39.
28. Gamboa A, Gamboa JL, Holmes C, Sharabi Y, Leon-Velarde F, Fischman GJ, et al. Plasma catecholamines and blood volume in native Andeans during hypoxia and normoxia. Clin Auton Res. 2006; 16 (1): 40-5.
29. Leuenberger U. Norephinephrine clearance is increased during acute hypoxia in humans. Am J Physiol. 1991; 261 (5 Pt 2): H1659-H1664.
30. Larsen AI, Hall C, Aukrust P, Aarsland T, Faris P, Dickstein K. Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure. Am J Cardiol. 2003; 92 (1): 91-4. (Pubitemid 36782323)
31. Cargill RI, Mcfarlane LC, Coutie WJ, Lipworth BJ. Acute neurohormonal responses to hypoxemia in man. Eur J Appl Physiol Occup Physiol. 1996; 72 (3): 256-60.
32. Pedersen BK, Steensberg A. Exercise and hypoxia: effects on leukocytes and interleukin-6-shared mechanisms? Med Sci Sports Exerc. 2002; 34 (12): 2004-13.
33. McAllister RM, Newcomer SC, Pope ER, Turk JR, Laughlin MH. Effects of chronic nitric oxide synthase inhibition on responses to acute exercise in swine. J Appl Physiol. 2008; 104 (1): 186-97.
34. Ennezat PV, Van Belle E, Asseman P, Cohen-Solal A, Evans T, Lejemtel TH. Steady endothelial nitric oxide synthase expression in heart failure. Acta Cardiol. 2007; 62 (3): 265-8.
35. Ide K, Worthley M, Anderson T, Poulin MJ. Effects of the nitric oxide synthase inhibitor L-NMMA on cerebrovascular and cardiovascular responses to hypoxia and hypercapnia in humans. J Physiol. 2007; 584 (Pt 1): 321-32.
36. Lundby C, Steensberg A. Interleukin-6 response to exercise during acute and chronic hypoxia. Eur J Appl Physiol. 2004; 91 (1): 88-93. (Pubitemid 38292355)
37. Minetto MA, Rainoldi A, Gazzoni M, Ganzit GP, Saba L, Paccotti P. Interleukin-6 response to isokinetic exercise in elite athletes: relationships to adrenocortical function and to mechanical and myoelectric fatigue. Eur J Appl Physiol. 2006; 98 (4): 373-82.
38. Plenz G, Song ZF, Tjan TD, Koenig C, Baba HA, Erren M, et al. Activation of the cardiac interleukin-6 system in advanced heart failure. Eur J Heart Fail. 2001; 3 (4): 415-21.
39. Maayer B, Holmer S, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H. Functional improvement in HF patients treated with beta-blockers is associated with a decline of cytokine levels. Int J Cardiol. 2005; 18 (2): 182-6. (Pubitemid 41096032)